Raleigh Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-231
Closed -$3.45K 885
2024
Q4
$3.45K Hold
231
﹤0.01% 762
2024
Q3
$4.42K Hold
231
﹤0.01% 711
2024
Q2
$4.78K Hold
231
﹤0.01% 679
2024
Q1
$4.34K Hold
231
﹤0.01% 678
2023
Q4
$3.33K Hold
231
﹤0.01% 806
2023
Q3
$4.01K Hold
231
﹤0.01% 717
2023
Q2
$4.81K Hold
231
﹤0.01% 647
2023
Q1
$5.43K Buy
+231
New +$6.2K ﹤0.01% 599
2022
Q4
Sell
-183
Closed -$4K 861
2022
Q3
$4K Buy
183
+73
+66% +$2.2K ﹤0.01% 542
2022
Q2
$4K Buy
110
+1
+0.9% +$35 ﹤0.01% 479
2022
Q1
$4K Sell
109
-9
-8% -$308 ﹤0.01% 489
2021
Q4
$4K Buy
+118
New +$3.84K ﹤0.01% 250

Other funds holding OGN

Raleigh Capital Management's OGN Position: Q1 2025 in Review

Raleigh Capital Management sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 231 shares — an estimated $3.45K sold.

Raleigh Capital Management first reported a position in OGN in Q4 2021 and held it in 12 quarters. The position peaked at $5.43K in Q1 2023. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Raleigh Capital Management reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 231 Organon & Co shares in Q1 2025, an estimated $3.45K.
  • Raleigh Capital Management first reported a position in Organon & Co in Q4 2021 and held it in 12 quarters.
  • Raleigh Capital Management's Organon & Co position peaked at $5.43K in Q1 2023.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Raleigh Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.